green
Positive treatment
1.6 score
Treatment trajectory · 1997 → 2026 · click a year to view as-of
1997
2011
2026
Top citers, strongest first. 3 distinct citers.
How cited ↗
discussed
Cited "see"
KW-2, LLC v. Asus Computer International
See Ortho Pharmaceutical Corp. v. Genetics Institute, Inc., 52 F.3d 1026, 1031 (Fed.Cir.) (although “[pjracticfe of the invention by others may indeed cause [the licensee] pecuniary loss... economic injury alone does not provide standing to sue under the patent statute”) (internal citations omitted), cert. denied, 516 U.S. 907 , 116 S.Ct. 274 , 133 L.Ed.2d 195 (1995). .
discussed
Cited "see, e.g."
Fed. Sec. L. Rep. P 90,266 Irene L. Wright, on Behalf of Herself and All Others Similarly Situated v. Ernst & Young LLP
See SEC v. First Jersey Securities, 101 F.3d 1450, 1471 (2d Cir.1996) (“Primary liability may be imposed ‘not only on persons'who made fraudulent misrepresentations but also on those who had knowledge of the fraud and assisted in its perpetration.’ ” (citation omitted)), cert. denied, — U.S. -, 118 S.Ct. 57 , 139 L.Ed.2d 21 (1997); see also In re Software Toolworks Inc. Securities Litigation, 50 F.3d 615 , 628 n. 3 (9th Cir.1994), ce rt. denied, 516 U.S. 907 , 116 S.Ct. 274 , 133 L.Ed.2d 195 (1995); In re ZZZZ Best Securities Litigation, 864 F.Supp. 960 , 970 n. 12 (C.D.Cal.1994).
discussed
Cited "see, e.g."
Rothschild v. Ford Motor Co.
See also Ortho Pharmaceutical Corp. v. Genetics Institute, Inc., 52 F.3d 1026, 1033 (Fed.Cir.) (“a U.S. patent grants rights to exclude others from making, using, and selling the patent invention only in the United States”), cert. denied, 516 U.S. 907 , 116 S.Ct. 274 , 133 L.Ed.2d 195 (1995).
Retrieving the full opinion text from the archive…
Shoemaker, Former Chief, Ohio Adult Parole Authority
v.
Kellogg
v.
Kellogg
No. 94-1964.
Supreme Court of the United States.
Oct 2, 1995.
Published
C. A. 6th Cir. Motion of respondent Glen S. Kellogg for leave to proceed in forma pauperis granted. Certiorari denied.